diphenyleneiodonium has been researched along with manganese in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Geiszt, M; Ligeti, E; Nemet, K; Rada, BK; Roos, D; Van Bruggen, R | 1 |
Bernhardt, F; Cordi, A; Gaertner, R; Jaulmes, A; Lockhart, BP; Rolland-Valognes, G; Rupin, A; Sansilvestri-Morel, P; Verbeuren, TJ; Wierzbicki, M | 1 |
2 other study(ies) available for diphenyleneiodonium and manganese
Article | Year |
---|---|
Calcium signalling is altered in myeloid cells with a deficiency in NADPH oxidase activity.
Topics: Calcium; Calcium Signaling; Cell Line; Cells, Cultured; Enzyme Inhibitors; Granulomatous Disease, Chronic; Humans; Leukemia, Promyelocytic, Acute; Manganese; Membrane Potentials; Myeloid Cells; NADPH Oxidases; Neutrophils; Nitric Oxide Synthase; Onium Compounds; Superoxides; Tetradecanoylphorbol Acetate | 2003 |
Nox4 mediates the expression of plasminogen activator inhibitor-1 via p38 MAPK pathway in cultured human endothelial cells.
Topics: Acetylcysteine; Benzopyrans; Cells, Cultured; Dose-Response Relationship, Drug; Endothelial Cells; Gene Expression Regulation; Humans; Manganese; MAP Kinase Signaling System; NADPH Oxidase 4; NADPH Oxidases; Onium Compounds; Organometallic Compounds; p38 Mitogen-Activated Protein Kinases; Plasminogen Activator Inhibitor 1; Reactive Oxygen Species; RNA, Messenger; RNA, Small Interfering | 2009 |